Blood Donation Screening Tests: Complete Panel and Rationale
Standard Blood Donor Screening in the US (FDA/AABB)
Every unit undergoes mandatory testing before release.
Donor Eligibility Screening (Pre-Donation)
- Health history questionnaire (risk behaviors, travel, medications).
- Physical: Hb/Hct (fingerstick), BP, pulse, temperature.
- Weight ≥110 lb (50 kg).
Laboratory Testing on Each Donation
| Test | Method | Purpose |
|---|---|---|
| ABO/Rh typing | Automated agglutination | Compatibility for transfusion |
| Antibody screen (unexpected) | Indirect antiglobulin | Detect alloantibodies (Kell, Duffy, Kidd, etc.) |
| HIV-1/2 Ag/Ab | Chemiluminescence (4th gen) | Window ~18 days |
| HBV: HBsAg, anti-HBc, HBV DNA | NAT + serology | Window ~21 days (DNA) |
| HCV: Ab + HCV RNA | NAT + serology | Window ~7 days (RNA) |
| Syphilis (Treponema pallidum) | Treponemal (EIA/CIA) + nontreponemal (RPR) | Detect active/past |
| HTLV-I/II Ab | EIA | Endemic areas, transfusion-associated |
| West Nile Virus RNA | NAT (seasonal/universal) | Emerging threat |
| Zika Virus RNA | NAT (as needed) | Outbreak-responsive |
| Babesia (endemic areas) | Ab + PCR | Transfusion-transmitted |
| Chagas (T. cruzi) Ab | EIA | Risk-based / universal |
